jRCT2051220160已完成不适用
An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients who completed the 52 weeks of administration in the CNT-01-811 study.
- •Patients who voluntarily signed and dated the informed consent form.
排除标准
- •Patients with diabetic ketoacidosis.
- •Patients allergic to the ingredients of the investigational product.
结局指标
主要结局
-
Adverse event, Adverse drug reaction
次要结局
未报告次要终点
研究者
相似试验
招募中
Unknown
An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyJPRN-jRCT2051220160Akita Yasuhiko60
进行中（未招募）
2 期
Phase IIb/III Clinical Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic triglyceride deposit cardiomyovasculopathyJPRN-jRCT2051210177Akita Yasuhiko60
招募中
3 期
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleucelJPRN-jRCT2033230370Gina Bonaccorso10
招募中
不适用
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleuceljRCT2033230370Kite Pharma, Inc.10
已完成
2 期
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.on-small cell lung cancerJPRN-UMIN000000817agasaki Thoracic Oncology Group32